Interestingly, despite being the only other therapeutic in a phase 3 trial with (originally) mortality as the end point, Aviptadil was never issued a code. So far no drugs on that list have been denied.
Just wanted to remind everyone where things are at right now.... (I screwed up the administration method in the first version)
* Corrected entries that specified "central vein" to "peripheral vein". ** I've condensed the chart to remove entries for drug administration methods that are not used or likely to be approved.
XW013K6 - Trial completed and awaiting results
XW023U6 - Likely the AZ/J&J vaccine due for approval around 26Feb21
XW033H6 - Candidate not named (probably Merck/OncoImmune SacCovid)
XW033L6 - Most likely trial completion end of Mar21
Market Data 
Markets 
AI
